Baduanjin for ischemic heart failure with mildly reduced/preserved ejection fraction (BEAR Trial): A randomized controlled trial.
Jingen LiMeili YuYanhui WangSiming LiSiwei LiXue FengRuijie LiKeji ChenHao XuPublished in: Journal of evidence-based medicine (2024)
Adding Baduanjin to exercise-based cardiac rehabilitation for patients with ischemic HFmrEF or HFpEF are generally safe and could provide significant improvements in exercise capacity and quality of life.
Keyphrases
- ejection fraction
- heart failure
- high intensity
- aortic stenosis
- physical activity
- ischemia reperfusion injury
- resistance training
- clinical trial
- study protocol
- phase iii
- left ventricular
- cerebral ischemia
- atrial fibrillation
- randomized controlled trial
- phase ii
- coronary artery disease
- transcatheter aortic valve replacement
- open label
- aortic valve
- blood brain barrier
- double blind